Therapeutic Equivalence Study of HCP0910 250/50 Mcg to Seretide 250 Diskus in Asthmatic Patients

NCT01521455 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: HCP0910
DRUG: Seretide Diskus

Sponsor

Hanmi Pharmaceutical Company Limited